Governor Deval Patrick, Senate President Therese Murray and the Massachusetts Life Sciences Center (MLSC) announced nearly $400,000 in capital grant funding for Cape Cod Community College to fund major equipment upgrades in the College’s life sciences training facilities.
The $395,485 grant awarded to Cape Cod Community College (CCCC) will help to upgrade the equipment available in the biology and chemistry laboratory facilities on campus.
The Massachusetts Life Sciences Center (MLSC) and five global biopharmaceutical companies announced today the second round of funding from the Massachusetts Neuroscience Consortium (Consortium). The Consortium, the formation of which was announced in June of 2012 at the Bio International Convention, will fund pre-clinical neuroscience research at Massachusetts academic and research institutions. Participating companies include Biogen Idec, EMD Serono, Janssen Research & Development, LLC and Johnson & Johnson Innovation, Merck & Co., and Sunovion Pharmaceuticals.
Learn more about the program, and how to apply, by clicking here.
Oncovision, an innovative medical imaging technology company from Valencia, Spain, announced today the opening of its U.S. subsidiary, Oncovision, Inc., located in Boston. Oncovision plans to hire 4 to 5 employees in Boston by the end of 2014, and to open a manufacturing facility in 2015.
Joslin Diabetes Center opened its new Translational Center for the Cure of Diabetes at its campus in the heart of Boston’s Longwood Medical Area. Governor Deval L. Patrick cut the ceremonial ribbon, along with Joslin President & CEO, John Brooks and the President & CEO of the Massachusetts Life Sciences Center, Susan Windham-Bannister, Ph.D.
In January 2012, Joslin, the world leader in diabetes research and care received a $5 million grant from the Massachusetts Life Sciences Center (MLSC), among the highest amounts ever received to support diabetes research in Massachusetts. The grant was matched with $5.8 million in funds raised from generous Joslin donors, and a total of $10.8 million was used to build the comprehensive center.
Governor Deval Patrick and the Massachusetts Life Sciences Center (MLSC) announced a $500,000 capital grant for Western New England University to fund equipment related to the development of test and filtration platforms for cancer drug research and development. The Center also announced a $25,000 grant for Girls, Inc. of Holyoke to expand their Eureka! STEM program for underserved
At the 2014 MassBio Annual Meeting, Massachusetts Life Sciences President and CEO Susan Windham-Bannister Ph.D., accepted the organization’s Leading Impact Award on behalf of Governor Deval Patrick.
The Massachusetts Life Sciences Center (MLSC) announced the approval of a $75,000 capital planning grant to support a study of a regional incubation center for life science initiatives to be located in the city of New Bedford and operated in conjunction with the University of Massachusetts at Dartmouth and Bristol Community College.
Governor Deval Patrick joined the Massachusetts Life Sciences Center (MLSC) to celebrate the grand opening of LabCentral’s state-of-the-art, 28,000 square-foot facility in Kendall Square in Cambridge. The Governor also announced $5 million in additional capital funding from the MLSC for LabCentral to fund build-out of additional space of equal size near LabCentral’s existing 700 Main Street location, continuing the Patrick Administration’s dedication to expanding opportunities for innovative life sciences and biotech companies.
Governor Deval L. Patrick and the Massachusetts Life Sciences Center (MLSC) today announced nearly $6 million in grants to support lifesciences-related capital projects in the City of Boston, including $5 million for UMass Medical School’s MassBiologics to fund major lab and facility renovations. Grants were also awarded to The UMass Boston Venture Development Center and The Venture Café. This is in addition to more than $900,000 in funding that the MLSC announced this past December for equipment and supply grants at vocational technical schools and public high schools in the Boston area.
Lowell – March 28th, 2014 –Governor Deval Patrick and the Massachusetts Life Sciences Center (MLSC) today announced $7 million in capital grants for UMass Lowell and Middlesex Community College.
Beverly –March 28th, 2014 –Governor Deval L. Patrick and the Massachusetts Life Sciences Center (MLSC) today announced a $5 million capital grant for the Life Sciences Consortium of the North Shore (LSCNS), which consists of Endicott College, Gordon College, North Shore InnoVentures, North Shore Community College (NSCC), and Salem State University. The grant will fund major lab/facility and equipment upgrade projects at the member institutions and organizations.
The Massachusetts Life Sciences Center (MLSC) today announced Andrew Jay, DMD as the newest member of the organization’s Scientific Advisory Board (SAB). The Life Sciences Center’s 24-member SAB provides technical guidance and oversight around the MLSC’s funding and programmatic decisions. The expert panel ensures that decisions made at the MLSC are made based on merit and with scientific credibility and transparency. The SAB is chaired by Dr. Harvey F. Lodish, Member of the Whitehead Institute for Biomedical Research and Professor of Biology and Professor of Bioengineering at Massachusetts Institute of Technology. View Jay’s profile here.
Intellimedix, a company devoted to developing and applying novel methods to accelerate the discovery of new treatments and cures, with a focus on epilepsy and other neurological disorders, joined with the Massachusetts Life Sciences Center (MLSC), MassBio and DivcoWest Real Estate Investments to host a grand opening and ribbon cutting ceremony to officially open their new research lab in Cambridge, MA. The new facility is located at One Kendall Square.
Quincy College has been awarded a $500,000 Capital Grant from the Massachusetts Life Sciences Center. The grant will allow Quincy College’s Biotechnology and Compliance program to continue training its students on the single-use biomanufacturing equipment that is used by today’s biotechnology industry. The College currently offers associate degree and certificate programs in Biotechnology and Compliance. The funds are slated to purchase laboratory supplies and equipment and to assist in furthering curriculum development.
Governor Deval Patrick toured and visited with workers at Nuclea Biotechnologies, a biotechnology services company that has developed a novel technology platform to improve the efficiency of diagnostics and drug discovery research.
Headquartered in Pittsfield, with additional operations in Worcester and Cambridge, Nuclea has developed and is commercializing unique diagnostic tests for colon, breast, leukemia, lung and prostate cancer. Nuclea also performs research leading to novel molecular oncology companion diagnostics for the pharmaceutical and biotechnology industries.